Brutalist Biotech

• Sanofi signs €545M deal to explore Formation’s JAK/SYK inhibitor in new indication (19h)
• BrightGene tops Novo drug in diabetes ahead of Zepbound showdown (20h)
• Corxel, Sciwind post GLP-1 data as China's obesity push gathers pace (20h)

• Relentless innovation: Bold exploration in advancing therapeutic options for every patient, every discovery (14h)
• Top drug official at FDA reportedly set to exit next month (14h)
• Cidara stock soars as antiviral drug succeeds in flu study (16h)

• Politics collide with science ahead of new ACIP meeting (12h)
• Amgen plans more gradual MariTide dosing in Phase 3 (12h)
• FDA approves AstraZeneca, Daiichi Sankyo's Datroway in EGFR-mutated lung cancer (13h)

• Washington's Policy Shifts Are Driving Capital Away From Life-Saving Research (5h)
• FDA Conditional Pathway Not Necessary, Rare Disease Experts Say, While Applauding Intent (5h)
• Acting CDER Head Becomes Latest in String of FDA Leaders to Leave Agency (17h)

Bio IT World

• Pangaea Data, Alexion Collaboration, Dell to Develop Supercomputer, More (4h)
• Nanoneedle Patch Enables Non-Invasive Tissue Sampling Offering Spatiotemporal Insights (5d)
• Black Swan Initiative: Multi-Pronged Research Strategy Targets Multiple Myeloma Cure (6d)

• Why this health tech investor thinks AI could bring the ‘learning health system’ to life (54m)
• ‘Too many, too soon’? Debunking a common fear about kids’ vaccines (54m)
• Balkanization of vaccine policy raises concerns about vaccine uptake, insurance coverage, experts warn (54m)

• NVIDIA Releases Agentic AI Blueprint for Literature Review and Target Discovery (4d)
• Nabla Raises $70M Series C to Expand Agentic AI Platform for Clinical Workflows (5d)
• Axiom Bio Releases Human Liver Toxicity Dataset with 130,000 Compounds to Advance AI-based Toxicity Prediction (5d)

• Turning plastic into medicine: Closing the loop on pharma production (18h)
• Special Episode: The 2025 BIO International Convention (4d)
• Stem cell therapy: a potential cure for hearing loss? (4d)

• Brain Receptor Structure Revealed to Support Cerebellum Function Repair (7h)
• Scientific Data Crisis Holds Back CMC (11h)
• Rare Gene Mutation Delays Alzheimer’s by Damping Immune Cell Inflammatory Signaling (13h)

• Faith, Friendship and Finding Purpose After Breast Cancer (12h)
• A New Digital Platform Aims to Expand Access to Early Oncology Trials (14h)
• FDA Approves Datroway for EGFR-Mutated Advanced Lung Cancer (14h)

Contract Pharma*

• Novo Nordisk Axes Relationship with Hims & Hers (13h)
• Celltrion Opens UK Headquarters in Uxbridge (19h)
• Why Project Management Is the Real Differentiator for CDMOs (19h)

• NHS rolls out new initiative to identify pancreatic cancer earlier (22h)
• eXmoor and Signadori Bio enter cell therapy partnership (5d)
• Teva and Fosun Pharma partner on early-stage oncology drug (6d)

• More Than 50 Health Plans Commit to Simplifying Prior Authorization (9h)
• Why This Former OpenAI Exec Is Urging Health Leaders to ‘Specialize in Empathy’ (10h)
• Vertex Pharma’s Type 1 Diabetes Cell Therapy Shows Potential to Achieve Insulin Independence (14h)

• Veolia opens PFAS removal plant in Delaware (13h)
• Crystals defy their symmetry to discern chiral light (15h)
• Researchers turn plastic into paracetamol (16h)

The Pharma Letter*

• Lilly’s oral GLP-1 shows no liver safety issues in Phase III diabetes trial (16h)
• Medicus Pharma appoints COO; updates on SKNJCT-003 (16h)
• European approval for argenx expands autoimmune footprint (16h)

• Walking Through the First 3 Physician Visits for Patients with mHSPC (14h)
• Zanzalintinib/Atezolizumab Improves CRC Survival, Expands TKI's Role in Solid Tumors (14h)
• FDA Grants Accelerated Approval to Dato-DXd in Previously Treated EGFR+ NSCLC (15h)

• Analyst: Novo Nordisk shows “decisiveness” by dropping partner after dispute over generic drugs (56m)
• Him & Hers boss hits back after Novo's decision to end partnership (1h)
• Lundbeck drug granted special status in Europe and the US (2h)

• Hexanitrogen (12h)
• Stir Bars Can't Be Ignored (5d)
• AI Effects on Drug Patents (1w)

• Senator says ACIP next meeting should be postponed (41m)
• NHS records to be harnessed in pancreatic cancer screening (20h)
• EU kicks off review of GSK's linerixibat in PBC (21h)

• The significance of mAbs in drug discovery and development (1h)
• eBook: The significance of mAbs in drug discovery and development (1h)
• Study supports monovalent antibody in neuropsychiatric disease (21h)

Google News Biotech

• Gene Therapy Market Top Companies Study -Krystal Biotech, Inc., - openPR.com (15m)
• Citizens JMP reiterates Sana Biotechnology stock rating on diabetes data - Investing.com (27m)
• Danish BioTech startup Cellugy secures €8.1 million to eradicate microplastics in personal care products - EU-Startups (44m)